These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17188584)

  • 1. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile.
    Yuan K; Kong H; Guan Y; Yang J; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):236-40. PubMed ID: 17188584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
    Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.
    Wang C; Kong H; Guan Y; Yang J; Gu J; Yang S; Xu G
    Anal Chem; 2005 Jul; 77(13):4108-16. PubMed ID: 15987116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics].
    Yuan KL; Shi XZ; Lu X; Gao P; Xu GW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):719-24. PubMed ID: 18595246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA.
    Yi LZ; He J; Liang YZ; Yuan DL; Chau FT
    FEBS Lett; 2006 Dec; 580(30):6837-45. PubMed ID: 17141227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.
    Lu Y; A J; Wang G; Hao H; Huang Q; Yan B; Zha W; Gu S; Ren H; Zhang Y; Fan X; Zhang M; Hao K
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2882-8. PubMed ID: 18720470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid phase extraction procedure for urinary organic acid analysis by gas chromatography mass spectrometry.
    Liu A; Kushnir MM; Roberts WL; Pasquali M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):283-7. PubMed ID: 15171940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles.
    Yang J; Xu G; Hong Q; Liebich HM; Lutz K; Schmülling RM; Wahl HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):53-8. PubMed ID: 15556515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol.
    Zha W; A J; Wang G; Yan B; Gu S; Zhu X; Hao H; Huang Q; Sun J; Zhang Y; Cao B; Ren H
    Biomarkers; 2009 Sep; 14(6):372-80. PubMed ID: 19552617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.
    Li X; Xu Z; Lu X; Yang X; Yin P; Kong H; Yu Y; Xu G
    Anal Chim Acta; 2009 Feb; 633(2):257-62. PubMed ID: 19166731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy.
    Han LD; Xia JF; Liang QL; Wang Y; Wang YM; Hu P; Li P; Luo GA
    Anal Chim Acta; 2011 Mar; 689(1):85-91. PubMed ID: 21338761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry.
    Yin P; Mohemaiti P; Chen J; Zhao X; Lu X; Yimiti A; Upur H; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):322-7. PubMed ID: 18556250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis.
    Gao P; Lu C; Zhang F; Sang P; Yang D; Li X; Kong H; Yin P; Tian J; Lu X; Lu A; Xu G
    Analyst; 2008 Sep; 133(9):1214-20. PubMed ID: 18709197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
    Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
    Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fatty acids metabolic profiling analysis of coronary heart disease based on GC-MS and pattern recognition.
    Zheng X; Shen J; Liu Q; Wang S; Cheng Y; Qu H
    J Pharm Biomed Anal; 2009 Feb; 49(2):481-6. PubMed ID: 19058943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel noninvasive identification of biomarkers by analytical profiling of chronic wounds using volatile organic compounds.
    Thomas AN; Riazanskaia S; Cheung W; Xu Y; Goodacre R; Thomas CL; Baguneid MS; Bayat A
    Wound Repair Regen; 2010; 18(4):391-400. PubMed ID: 20492633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.
    Jones MG; Cooper E; Amjad S; Goodwin CS; Barron JL; Chalmers RA
    Clin Chim Acta; 2005 Nov; 361(1-2):150-8. PubMed ID: 15992788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.